Chen-lin L. Gao

Luzhou, 646000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

BDH1-mediated βOHB metabolism ameliorates diabetic kidney disease by activation of NRF2-mediated antioxidative pathway.

BDH1-mediated βOHB metabolism ameliorates diabetic kidney disease by activation of NRF2-mediated antioxidative pathway.

Journal: Aging

Published: August 01, 2023

Tumor-induced osteomalacia characterized by "painful knee joint with difficulty in moving": a case report.

Tumor-induced osteomalacia characterized by "painful knee joint with difficulty in moving": a case report.

Journal: BMC endocrine disorders

Published: November 20, 2021

Butyrate ameliorates alcoholic fatty liver disease via reducing endotoxemia and inhibiting liver gasdermin D-mediated pyroptosis.

Butyrate ameliorates alcoholic fatty liver disease via reducing endotoxemia and inhibiting liver gasdermin D-mediated pyroptosis.

Journal: Annals of translational medicine

Published: June 24, 2021

Higher Dietary Inflammatory Index Scores Increase the Risk of Diabetes Mellitus: A Meta-Analysis and Systematic Review.

Higher Dietary Inflammatory Index Scores Increase the Risk of Diabetes Mellitus: A Meta-Analysis and Systematic Review.

Journal: Frontiers in endocrinology

Published: April 09, 2021

Sodium Butyrate Improves Liver Glycogen Metabolism in Type 2 Diabetes Mellitus.

Sodium Butyrate Improves Liver Glycogen Metabolism in Type 2 Diabetes Mellitus.

Journal: Journal of agricultural and food chemistry

Published: June 29, 2019

Kuwanon G protects HT22 cells from advanced glycation end product-induced damage.

Kuwanon G protects HT22 cells from advanced glycation end product-induced damage.

Journal: Experimental and therapeutic medicine

Published: January 31, 2019

Sodium butyrate supplementation ameliorates diabetic inflammation in db/db mice.

Sodium butyrate supplementation ameliorates diabetic inflammation in db/db mice.

Journal: The Journal of endocrinology

Published: June 07, 2018

ATP2B1 Gene Silencing Increases NO Production Under Basal Conditions Through the Ca2+/calmodulin/eNOS Signaling Pathway in Endothelial Cells.

ATP2B1 Gene Silencing Increases NO Production Under Basal Conditions Through the Ca2+/calmodulin/eNOS Signaling Pathway in Endothelial Cells.

Journal: Hypertension research : official journal of the Japanese Society of Hypertension

Published: June 16, 2017

Decreased plasma neuregulin 4 concentration is associated with increased high-sensitivity C-reactive protein in newly diagnosed type 2 diabetes mellitus patients: a cross-sectional study.

Decreased plasma neuregulin 4 concentration is associated with increased high-sensitivity C-reactive protein in newly diagnosed type 2 diabetes mellitus patients: a cross-sectional study.

Journal: Acta diabetologica

Published: June 03, 2017

ATP2B1 gene Silencing Increases Insulin Sensitivity through Facilitating Akt Activation via the Ca2+/calmodulin Signaling Pathway and Ca2+-associated eNOS Activation in Endothelial Cells.

ATP2B1 gene Silencing Increases Insulin Sensitivity through Facilitating Akt Activation via the Ca2+/calmodulin Signaling Pathway and Ca2+-associated eNOS Activation in Endothelial Cells.

Journal: International journal of biological sciences

Published: February 14, 2017

The efficacy and safety of SGLT2 inhibitors for adjunctive treatment of type 1 diabetes: a systematic review and meta-analysis.

The efficacy and safety of SGLT2 inhibitors for adjunctive treatment of type 1 diabetes: a systematic review and meta-analysis.

Journal: Scientific reports

Published: August 03, 2016

Showing 1-11 of 11

Last Updated: 09/26/2026